235
Active Trials
58
Phase 1
89
Phase 2
90
Phase 3
18
Therapeutic Areas
Portfolio Concentration: 58% of active trials in Oncology
Oncology
136 active / 381 total
Prostate Cancer
24 active
5 Ph3
30 total since 2015
Solid Tumor (Advanced)
17 active
2 Ph3
39 total since 2015
NSCLC
12 active
1 Ph3
41 total since 2015
Breast Cancer
10 active
4 Ph3
31 total since 2015
CML
8 active
3 Ph3
15 total since 2015
ALL
7 active
2 Ph3
19 total since 2015
Non-Hodgkin Lymphoma
6 active
3 Ph3
21 total since 2015
Melanoma
6 active
18 total since 2015
Hematologic Malignancies
6 active
1 Ph3
11 total since 2015
Colorectal Cancer
5 active
15 total since 2015
Myelofibrosis
4 active
2 Ph3
9 total since 2015
Triple Negative Breast Cancer
3 active
15 total since 2015
SCLC
3 active
8 total since 2015
Glioblastoma
3 active
6 total since 2015
Mesothelioma
3 active
3 total since 2015
AML
2 active
13 total since 2015
MDS
2 active
11 total since 2015
Pancreatic Cancer
2 active
9 total since 2015
Brain Tumor
2 active
3 total since 2015
HER2- Breast Cancer
2 active
2 total since 2015
Lung Cancer (General)
1 active
9 total since 2015
Ovarian Cancer
1 active
1 Ph3
6 total since 2015
Head and Neck Cancer
1 active
5 total since 2015
Neuroendocrine Tumors
1 active
1 Ph3
4 total since 2015
Sarcoma
1 active
4 total since 2015
CLL
1 active
3 total since 2015
Gastric Cancer
1 active
2 total since 2015
Thyroid Cancer
1 active
1 Ph3
2 total since 2015
Endometrial Cancer
1 active
2 total since 2015
Multiple Myeloma
0 active
8 total since 2015
Esophageal Cancer
0 active
5 total since 2015
Renal Cell Carcinoma
0 active
4 total since 2015
Squamous Cell Carcinoma
0 active
3 total since 2015
Hepatocellular Carcinoma
0 active
3 total since 2015
Bladder Cancer
0 active
1 total since 2015
Cervical Cancer
0 active
1 total since 2015
Immunology
49 active / 162 total
Ankylosing Spondylitis
20 active
7 Ph3
54 total since 2015
Rheumatoid Arthritis
14 active
7 Ph3
48 total since 2015
Lupus
10 active
5 Ph3
16 total since 2015
Atopic Dermatitis
2 active
6 total since 2015
Ulcerative Colitis
2 active
1 Ph3
4 total since 2015
Psoriatic Arthritis
1 active
11 total since 2015
Psoriasis
0 active
23 total since 2015
Cardiovascular
22 active / 91 total
Myocardial Infarction
12 active
5 Ph3
33 total since 2015
Atrial Fibrillation
5 active
1 Ph3
12 total since 2015
Coronary Artery Disease
3 active
2 Ph3
8 total since 2015
Hypertension
2 active
11 total since 2015
Heart Failure
0 active
24 total since 2015
Hypertrophic Cardiomyopathy
0 active
2 total since 2015
Stroke
0 active
1 total since 2015
CNS
19 active / 60 total
Multiple Sclerosis
14 active
8 Ph3
32 total since 2015
Alzheimer's Disease
2 active
8 total since 2015
Huntington's Disease
2 active
1 Ph3
3 total since 2015
ALS
1 active
3 total since 2015
Migraine
0 active
8 total since 2015
Major Depression
0 active
4 total since 2015
Schizophrenia
0 active
1 total since 2015
Parkinson's Disease
0 active
1 total since 2015
Rare Disease
14 active / 33 total
Metabolic
7 active / 52 total
Dyslipidemia
5 active
4 Ph3
16 total since 2015
Diabetic Complications
2 active
15 total since 2015
NASH/NAFLD
0 active
9 total since 2015
Obesity
0 active
5 total since 2015
Type 2 Diabetes
0 active
3 total since 2015
Type 1 Diabetes
0 active
2 total since 2015
Diabetes (General)
0 active
2 total since 2015
Urology
6 active / 22 total
Respiratory
3 active / 58 total
Ophthalmology
2 active / 26 total
Renal
2 active / 6 total
Infectious Disease
1 active / 18 total
Dermatology
1 active / 4 total
Musculoskeletal
0 active / 19 total
Gastrointestinal
0 active / 4 total
Pain
0 active / 3 total
Hepatology
0 active / 1 total
Women's Health
0 active / 1 total
Endocrine
0 active / 1 total
Click an indication to see competitive landscape (all sponsors in that indication).
Data: ClinicalTrials.gov (2015+)